Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 50.19%28.28M | 3,312.53%13.08M | -49.63%3.37M | 0.46%11.31M | -59.31%527K | 8.47%18.83M | -106.48%-407K | 53.56%6.68M | 19.53%11.26M | 148.09%1.3M |
Net income from continuing operations | 111.28%6.15M | 124.31%7.89M | -113.33%-5.72M | 94.20%-494K | 140.94%4.48M | -607.24%-54.57M | -137.05%-32.44M | -346.69%-2.68M | -207.54%-8.52M | -259.93%-10.93M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 742.68%16.38M | 1,635,800.00%16.36M | ---- | ---- | ---- |
Depreciation and amortization | -37.50%17.09M | -19.29%4.32M | -41.81%4.39M | -41.95%4.03M | -42.03%4.36M | -13.88%27.35M | -30.82%5.35M | -2.43%7.54M | -15.98%6.94M | -6.40%7.52M |
Deferred tax | -17.80%2.25M | -42.10%1.54M | -480.30%-251K | ---- | ---- | 1,771.34%2.74M | 2,567.59%2.67M | 335.71%66K | ---- | ---- |
Other non cash items | -205.20%-8.27M | -217.48%-10.1M | 246.87%6.27M | -359.05%-930K | -210.60%-3.52M | 49.99%7.86M | 107.31%8.6M | -1,241.98%-4.27M | -1.64%359K | 790.48%3.18M |
Change In working capital | -81.25%1.34M | 4,839.62%7.85M | -158.77%-4.03M | -61.02%3.42M | -2,683.49%-5.9M | 148.24%7.16M | -97.86%159K | 76.70%-1.56M | 269.26%8.77M | 97.96%-212K |
-Change in receivables | -69.21%4.38M | 307.92%998K | -90.92%671K | -78.01%1.8M | 208.64%918K | 101,592.86%14.24M | -24.03%-480K | 326.66%7.39M | 87.28%8.17M | -20.20%-845K |
-Change in prepaid assets | 607.82%2.4M | 356.32%3.5M | -386.57%-2.97M | 110.53%241K | 12,415.38%1.63M | -106.80%-473K | -82.04%767K | -65.48%1.04M | -162.60%-2.29M | 100.33%13K |
-Change in payables and accrued expense | 40.70%-6.26M | 209.81%1.98M | 47.23%-2.67M | 136.02%1.73M | -758.88%-7.31M | -95.36%-10.56M | 54.01%-1.8M | -178.98%-5.06M | 26.60%-4.81M | 182.95%1.11M |
-Change in other current assets | 279.78%1.37M | 133.48%1.08M | 156.50%239K | -44.00%56K | -102.26%-5K | --361K | --463K | ---423K | --100K | --221K |
-Change in other current liabilities | 87.69%-343K | 255.08%909K | 147.68%278K | -112.47%-818K | 65.69%-712K | 65.57%-2.79M | -97.14%256K | 93.52%-583K | 93.84%-385K | -16.57%-2.08M |
-Change in other working capital | -103.26%-208K | -164.26%-615K | 110.67%418K | -94.85%411K | -130.92%-422K | 176.80%6.38M | 164.97%957K | -2.43%-3.92M | 2,104.77%7.98M | 152.16%1.37M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 50.19%28.28M | 3,312.53%13.08M | -49.63%3.37M | 0.46%11.31M | -59.31%527K | 8.47%18.83M | -106.48%-407K | 53.56%6.68M | 19.53%11.26M | 148.09%1.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -445.53%-13.13M | -120.42%-4.02M | 71.16%-1.6M | 23.94%-3.71M | 30.48%-3.8M | 128.86%3.8M | 502.23%19.69M | -23.14%-5.55M | -398.84%-4.87M | -1.32%-5.47M |
Capital expenditure reported | 29.86%-13.03M | 19.15%-3.16M | 38.79%-3.25M | 30.03%-3.33M | 28.47%-3.29M | 6.00%-18.57M | 13.22%-3.91M | -16.58%-5.31M | 12.73%-4.76M | 12.41%-4.59M |
Net PPE purchase and sale | -45.62%-1.9M | -1,075.34%-858K | 39.57%-142K | -221.19%-379K | 40.98%-517K | 7.53%-1.3M | 81.14%-73K | 47.54%-235K | 71.84%-118K | -468.83%-876K |
Net intangibles purchase and sale | --278K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | -93.60%1.52M | --0 | ---- | ---- | ---- | 195.93%23.67M | --23.67M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -445.53%-13.13M | -120.42%-4.02M | 71.16%-1.6M | 23.94%-3.71M | 30.48%-3.8M | 128.86%3.8M | 502.23%19.69M | -23.14%-5.55M | -398.84%-4.87M | -1.32%-5.47M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 70.70%-5.85M | 96.24%-469K | 89.24%-279K | -14.24%-2.98M | 7.39%-2.13M | -50.49%-19.98M | -442.50%-12.48M | -5.45%-2.59M | 61.33%-2.61M | -29.08%-2.3M |
Net issuance payments of debt | --62.54M | ---469K | ---469K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net preferred stock issuance | -483.11%-57.58M | --0 | --0 | ---- | ---- | -46.54%-9.87M | ---9.87M | --0 | ---- | ---- |
Cash dividends paid | 56.76%-4.26M | --0 | --0 | 13.95%-2.13M | 7.35%-2.13M | -52.56%-9.85M | -13.19%-2.6M | -7.70%-2.48M | -3,071.79%-2.47M | -29.03%-2.3M |
Proceeds from stock option exercised by employees | 3,050.00%236K | --0 | ---- | ---- | ---- | ---8K | ---8K | ---- | ---- | ---- |
Net other financing activities | -2,628.11%-6.79M | --0 | 60.68%-46K | ---- | ---- | -200.00%-249K | --0 | 26.88%-117K | ---131K | ---1K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 70.70%-5.85M | 96.24%-469K | 89.24%-279K | -14.24%-2.98M | 7.39%-2.13M | -50.49%-19.98M | -442.50%-12.48M | -5.45%-2.59M | 61.33%-2.61M | -29.08%-2.3M |
Net cash flow | ||||||||||
Beginning cash position | 12.09%24.57M | 43.55%25.23M | 22.34%23.65M | 22.75%19.1M | 12.09%24.57M | -30.42%21.92M | -22.18%17.57M | -24.24%19.33M | -28.38%15.56M | -30.42%21.92M |
Current changes in cash | 250.83%9.3M | 26.27%8.59M | 202.06%1.49M | 22.42%4.63M | 16.51%-5.41M | 129.18%2.65M | 843.06%6.8M | 44.20%-1.46M | -12.37%3.78M | 34.43%-6.47M |
Effect of exchange rate changes | -49,500.00%-494K | -320.10%-438K | 131.21%93K | -530.77%-82K | -159.29%-67K | 100.20%1K | -21.03%199K | 5.99%-298K | 97.55%-13K | 17.71%113K |
End cash Position | 35.83%33.38M | 35.83%33.38M | 43.55%25.23M | 22.34%23.65M | 22.75%19.1M | 12.09%24.57M | 12.09%24.57M | -22.18%17.57M | -24.24%19.33M | -28.38%15.56M |
Free cash flow | 1,378.18%13.36M | 306.15%9.05M | -102.38%-27K | 19.09%7.61M | 21.53%-3.28M | 72.55%-1.05M | -416.88%-4.39M | 273.81%1.14M | 79.81%6.39M | 48.41%-4.18M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |